— News and commentary from the endocrinology world
September 15, 2026
• 2 min read
An international consensus panel outlined the first clinical framework for implementing general-population screening for islet autoantibodies to catch early-stage type 1 diabetes. (Diabetologia)
Another international consensus offered updated recommendations tailored specifically for smoking cessation in people with type 2 diabetes. (Diabetes Research and Clinical Practice)
Novo Nordisk, maker of the blockbuster drug semaglutide (Ozempic, Wegovy), will slim down its name to just Novo as part of a rebranding effort, though Novo Nordisk A/S will remain its legal name. (Reuters via AOL)
The FDA cleared Beta Bionics’ Mint, a smartphone-controlled patch pump that features a reusable and disposable design, requires no recharging, and integrates with major continuous glucose monitors.
In a small randomized trial, eating only between 12:00 p.m. and 8:00 p.m. led to a greater reduction in HbA1c levels among adults with type 1 diabetes compared with continuous daily calorie restriction. (Diabetes Care)
Tennis player Alexander Zverev, who has type 1 diabetes, could be seen checking his blood sugar levels on a phone multiple times during his U.S. Open final win on Sunday. (Athlon Sports)
High-frequency spinal cord stimulation provided greater pain relief and sensory improvement compared with conventional medical management for patients with painful diabetic neuropathy in a randomized trial. (Diabetes Care)
The prevalence of clinical obesity among U.S. adolescents increased from 14.2% in 1999-2000 to 18.2% in 2021-2023, though preclinical obesity rates remained stable, national survey data showed. (JAMA Pediatrics)
A new Endocrine Society scientific statement outlined future research priorities aimed at delivering more personalized, long-term care for people living with obesity. (Endocrine Reviews)
Smoking at any point in life and exposure to second-hand smoke may negatively affect fertility, a World Health Organization report warned.
Review authors highlighted an urgent need for clinical trials investigating GLP-1 drugs in reproductive-age individuals to evaluate fertility outcomes and pregnancy safety. (Endocrinology and Metabolism Clinics of North America)
An increasing number of women are seeking off-label testosterone therapy to manage menopause symptoms, but many are facing prescription delays and pharmacy refusals. (Reuters via AOL)
Sen. Kirsten Gillibrand (D-N.Y.) will convene the first-ever congressional hearing dedicated to federal research funding for menopause. (New York Times)
